AZ supplies 20 million doses of COVID-19 vaccines to Korea

AZ, official statement after government announcement, "We are happy to supply for the public interest"

Government secures COVID-19 vaccines for 44 million people including from Pfizer and Modena, it will be introduced from February

The government announced a contract with AstraZeneca and other COVID-19 vaccine developers on the 8th, and AstraZeneca Korea said, "We are pleased to be able to supply (vaccine) for the public benefit." Korea AstraZeneca (CEO, Sang-pyo Kim) said on the day, "According to the contract with the KDCA, we will supply 20 million doses of AZD1222 (for 10 million people) to Korea." COVID-19 vaccine candidates being developed jointly with Oxford University This is the result of discussions on domestic supply after signing a letter of intent for cooperation with the MOHW and SK Bioscience in July.

 

An official from AstraZeneca Korea said, "We are pleased to be able to supply the vaccine to Korea for the public benefit through the signing of a supply contract for AZD1222 vaccine." He added, "I hope that we will be able to respond to the urgent demands of public health to protect the public's health and contribute to the government's efforts to fight COVID-19." He added, "As we have accurately disclosed the results of interim analysis of vaccine clinical studies through publication in authoritative academic journals, we will continue to verify the effectiveness and safety profile of vaccines based on scientific evidence." Previously, the government signed a contract for supply of 10 million people with AstraZeneca, and the government announced that it has confirmed the supply of 10 million people (20 million batches) from Pfizer and Modena respectively.

 

It also secured about 10 million people from COVAX Facility and 4 million people from Janssen.

 

COVAX Facility aims to equally supply vaccines up to 20% of the population by the end of 2021, focusing on the World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI, vaccine development), and the Global Vaccine Alliance (GAVI, vaccine supply).

 

A total of 44 million vaccines have been secured in this way.

 

The government plans to introduce the vaccine that it purchased in advance from February next year.